Core Scientific Director Purchases 6,000 Shares

Overview

• The SEC Form 4 reports that director Elizabeth Crain bought 6,000 shares of Core Scientific common stock in multiple trades on Aug. 20, 2026.
• The purchases executed at prices between $18.27 and $18.34 produced a weighted average cost of $18.33 per share, according to the filing.
• After the transactions Crain directly holds 71,348 shares, which the filing records as her full reported beneficial ownership and represents about 0.02% of the company.
• The filing ties the trade to Core Scientific’s public profile, noting the company’s digital-asset mining and colocation business and reported metrics such as roughly $5.5 billion market value and $440.3 million in trailing revenue.
• Because Form 4s are routine disclosures, the practical effects are mainly informational for investors; the buy could be seen as a small vote of confidence but is unlikely on its own to change market views given the low ownership stake.